$TPII Provides Update on EEL Diesel Hybrid Genset

New Post Public Reply Private Reply Replies (0) Message Board
louied91
236
$TPII Provides Update on EEL Diesel Hybrid Genset Trials

https://www.accesswire.com/693353/tpii-provid...set-trials

LAS VEGAS, NV / ACCESSWIRE / March 16, 2022 / Triad Pro Innovators, Inc. (OTC PINK:TPII) is pleased to update its shareholders on the progress of the ongoing EEL Diesel Hybrid Genset field tests.

Unit now with major Canadian oil company

Following successful independent validation testing by Frontier Power Products, the company is pleased to announce that the test unit is now with a major Canadian oil company located in Fort McMurray, Canada. Here the company has deployed the unit in a live test scenario.

The current tests aim to evaluate the viability of replacing a fleet of several hundred traditional diesel generators operated by the oil company. In addition to the EEL Genset's long-term fuel and maintenance cost savings of up to 90%, the oil company currently evaluating the unit is also seeing additional motivation to convert to greener alternatives owing to ESG goals.

EEL Diesel Hybrid Genset lives up to cold-climate expectations

A major factor driving interest in the EEL Diesel Hybrid Genset is its ability to operate in extreme cold temperatures - a fundamental roadblock holding lead-acid and lithium-based technologies from widespread adoption in cold climates. In this respect, TPII is pleased to confirm that the test unit has delivered on expectations.

When TPII representative attended the test start in Fort McMurray, temperatures were at -25°C, and the unit had been stored outdoors for several days. Despite the harsh conditions, the EEL started without a problem, and it continues to operate as anticipated in sustained extreme cold conditions.

The unit has been performing autonomously as designed. The daytime low temperatures on the first three of the five days was -25c to -30c.

To ensure the diesel engine will start during the cold nights; the EEL Power unit has a block and oil pan heater installed and controlled by a thermostat.

The two heaters combined consume approximately 700 watts.

During the three nights when temperatures were -25c or colder, the block and oil pan heaters turned on 5 times for approximately 45 minutes during each cycle.

"We're extremely pleased to have real-world validation of the EEL Diesel Hybrid Genset's capabilities in extremely cold conditions," said TPII CEO Murray Goldenberg. "We knew the unit was more than capable of operating in a lab environment at temperatures as low as -50°C, but operating in an outdoor work environment can always bring unexpected variables with it, and this field test has demonstrated that the EEL can handle them."

Companies have major incentives to consider EEL Diesel Hybrid Genset

As the EEL Diesel Hybrid Genset trials continue to validate the unit's capabilities, the company expects to see a strong order volume developing. In addition to the unit's well-proven cost and maintenance-saving benefits, companies are also being incentivized by ongoing pressure to seek greener, more climate-friendly solutions to energy generation.

Company CEO Murray Goldenberg said, "When you consider everything, our EEL Diesel Hybrid Genset really is a no-brainer. Even if we take climate considerations out of the equation, the fuel and maintenance cost savings delivered by the EEL make for an extremely compelling case. Once you factor for climate considerations as well, there is no alternative solution for remote communities and industrial operators where extreme weather conditions render other solutions entirely infeasible."

Triad Pro Innovators, Inc. (TPII) Stock Research Links

TPII Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading